Financials

  • Market Capitalization 12.56 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-45.32
市销率
13.63

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
802
CORT
Corcept Therapeutics Incorporated - Common Stock
116.93 USD-2.40%-3.75%+23.08%+59.37%12.64 B USD
803
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
65.29 USD-0.49%-3.35%+5.19%+13.47%12.64 B USD
809
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
88.59 USD-0.59%+0.50%+3.54%+126.57%12.51 B USD
824
HALO
Halozyme Therapeutics, Inc. - Common Stock
106.92 USD-0.13%+0.68%+28.70%+60.06%12.14 B USD

新闻